Abstract
Pleiotropic drug resistance (PDR) is a well-described phenomenon occurring in fungi. PDR shares several similarities with processes in bacteria and higher eukaryotes. In mammalian cells, multidrug resistance (MDR) develops from an initial single drug resistance, eventually leading to a broad cross-resistance to many structurally and functionally unrelated compounds. Notably, a number of membrane-embedded energy-consuming ATP-binding cassette (ABC) transporters have been implicated in the development of PDR/MDR phenotypes. The yeast Saccharomyces cerevisiae genome harbors some 30 genes encoding ABC proteins, several of which mediate PDR. Therefore, yeast served as an important model organism to study the functions of evolutionary conserved ABC genes, including those mediating clinical antifungal resistance in fungal pathogens. Moreover, yeast cells lacking endogenous ABC pumps are hypersensitive to many antifungal drugs, making them suitable for functional studies and cloning of ABC transporters from fungal pathogens such as Candida albicans. This review discusses drug resistance phenomena mediated by ABC transporters in the model system S. cerevisiae and certain fungal pathogens.
Keywords: Fungal ABC transporters, PDR network, drug resistance, stress, regulation
Current Drug Targets
Title: Fungal ATP-Binding Cassette (ABC) Transporters in Drug Resistance & Detoxification
Volume: 7 Issue: 4
Author(s): Gyorgy Sipos and Karl Kuchler
Affiliation:
Keywords: Fungal ABC transporters, PDR network, drug resistance, stress, regulation
Abstract: Pleiotropic drug resistance (PDR) is a well-described phenomenon occurring in fungi. PDR shares several similarities with processes in bacteria and higher eukaryotes. In mammalian cells, multidrug resistance (MDR) develops from an initial single drug resistance, eventually leading to a broad cross-resistance to many structurally and functionally unrelated compounds. Notably, a number of membrane-embedded energy-consuming ATP-binding cassette (ABC) transporters have been implicated in the development of PDR/MDR phenotypes. The yeast Saccharomyces cerevisiae genome harbors some 30 genes encoding ABC proteins, several of which mediate PDR. Therefore, yeast served as an important model organism to study the functions of evolutionary conserved ABC genes, including those mediating clinical antifungal resistance in fungal pathogens. Moreover, yeast cells lacking endogenous ABC pumps are hypersensitive to many antifungal drugs, making them suitable for functional studies and cloning of ABC transporters from fungal pathogens such as Candida albicans. This review discusses drug resistance phenomena mediated by ABC transporters in the model system S. cerevisiae and certain fungal pathogens.
Export Options
About this article
Cite this article as:
Sipos Gyorgy and Kuchler Karl, Fungal ATP-Binding Cassette (ABC) Transporters in Drug Resistance & Detoxification, Current Drug Targets 2006; 7 (4) . https://dx.doi.org/10.2174/138945006776359403
DOI https://dx.doi.org/10.2174/138945006776359403 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting NS5B RNA-Dependent RNA Polymerase for Anti-HCV Chemotherapy
Current Drug Targets - Infectious Disorders Astrocyte-Microglia Cooperation in the Expression of a Pro-Inflammatory Phenotype
CNS & Neurological Disorders - Drug Targets Reporting Rates of Yellow Fever Vaccine 17D or 17DD-Associated Serious Adverse Events in Pharmacovigilance Data Bases: Systematic Review
Current Drug Safety Natural Monophenols as Therapeutics, Antioxidants and Toxins; Electron Transfer, Radicals and Oxidative Stress
The Natural Products Journal Substance Abuse, HIV-1 and Hepatitis
Current HIV Research The Effects of TNF α Antagonist Therapy on Bone Metabolism in Rheumatoid Arthritis: A Systematic Review
Current Drug Targets Electrochemistry in the Mimicry of Oxidative Drug Metabolism by Cytochrome P450s
Current Drug Metabolism Brain Delivery of Chemotherapeutics in Brain Cancer
Anti-Cancer Agents in Medicinal Chemistry The Mediating Effect of Different Exercise Programs on the Immune Profile of Frail Older Women with Cognitive Impairment
Current Pharmaceutical Design Conserved Domains, Residues, WebLogo and Active Sites of Caspase- Cascades Related to Apoptotic Signaling Pathway
Current Bioinformatics Molecular Concept of Diabetic Wound Healing: Effective Role of Herbal Remedies
Mini-Reviews in Medicinal Chemistry Enantioselective Baeyer-Villiger Oxidations
Current Organic Chemistry Therapeutic Use of Chemokines
Current Pharmaceutical Design Best Practice for Atrial Fibrillation Patient Education
Current Pharmaceutical Design Purification of Transcription Factors and Identification with Mass Spectrometry
Current Analytical Chemistry Combining Oncolytic Virotherapy and Cytotoxic Therapies to Fight Cancer
Current Pharmaceutical Design Patent Selections:
Recent Patents on Regenerative Medicine Scorpion Toxins Targeting Voltage-gated Sodium Channels Associated with Pain
Current Pharmaceutical Biotechnology Chemistry of the Genus Dorstenia
Current Organic Chemistry Selected Players in the Inflammation Cascade and Drugs That Target These Inflammation Genes Against Metastasis
Anti-Cancer Agents in Medicinal Chemistry